- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
- Premium Tools
- Real Money
- Real Money Pro
- Action Alerts PLUS
- Stocks Under $10
- Breakout Stocks
- Options Profits
Latest Commentary
Real Money: Independent market insight from a veteran team of trusted Wall Street pros.
• Up-to-the-minute reports on market activity
• Actionable trade ideas
• Up-to-the-minute reports on market activity
• Actionable trade ideas
Latest Strategies
Real Money Pro: Professional tools and specific trade ideas for active investors.
• Information-packed market flow providing trade ideas, fast
• Dynamic interface with professional-grade analytical tools
• Full, unlimited access to Real Money
• Information-packed market flow providing trade ideas, fast
• Dynamic interface with professional-grade analytical tools
• Full, unlimited access to Real Money
Latest Alert
May 17, 2013 | 06:41 PM EDT
We plan to continue building up our financial and technology positions over the coming weeks. FULL ALERT »
Action Alerts PLUS: Jim Cramer and Stephanie Link actively manage a real money portfolio for Jim's charitable trust.
• Timely trade alerts including price targets
• Unique insight into market movements
• Guidance on how to trade right alongside Jim and Stephanie
• Timely trade alerts including price targets
• Unique insight into market movements
• Guidance on how to trade right alongside Jim and Stephanie
Latest Alert
May 17, 2013 | 04:34 PM EDT
We used the strength this week to take some profits in three model portfolio positions, and we added to two other holdings. FULL ALERT »
Stocks Under $10: David Peltier manages a portfolio of affordable stocks with huge upside potential.
• Identify fast-growing small-cap stock opportunities
• Buy and sell alerts allow you to analyze overlooked opportunities quickly
• In-depth reports and research packed with proprietary analysis
• Identify fast-growing small-cap stock opportunities
• Buy and sell alerts allow you to analyze overlooked opportunities quickly
• In-depth reports and research packed with proprietary analysis
Latest Alert
May 17, 2013 | 10:07 AM EDT
There is some news on three of our model portfolio holdings. Here are the highlights. FULL ALERT »
Breakout Stocks: Bryan Ashenberg, CFA, manages a portfolio of small and mid-cap stocks with high growth potential.
• Identify industry-changing macrotrends in their infancy
• Timely trade alerts loaded with detailed research
• Frequent communication about all Bryan's portfolio holdings
• Identify industry-changing macrotrends in their infancy
• Timely trade alerts loaded with detailed research
• Frequent communication about all Bryan's portfolio holdings
Latest Commentary
Options Profits: Day in and day out, our team of professional options traders search for inventive plays for trading spikes in market activity, emerging trends, and breaking news and events. These veterans reveal all their charts and technical data — delivering daily strategies and insightful commentary written specifically for the options trader plus 40 options trade ideas per week!
Edwards Life Sciences Corp. (EW)
EW (NYSE:Health Services)
$67.06
-1.55
-2.26%
Today's Range: 66.41 - 69.23 |
EW Avg Daily Volume: 1,359,300
| Last Update: 05/17/13 - 4:00 PM EDT |
| Volume: 2,044,869 |
| YTD Performance: -25.63% |
| Open: $68.68 |
| Previous Close: $68.61 |
| 52 Week Range: $62.34 - $110.79 |
| Oustanding Shares: 112,961,747 |
| Market Cap: 7,750,305,462 |
Analysts Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 |
| Moderate Buy | 0 | 1 | 1 | 1 |
| Hold | 9 | 6 | 7 | 7 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 2 | 2 | 2 |
| Mean Rec. | 2.22 | 2.24 | 2.28 | 2.28 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.77 | $0.70 | $3.05 | $3.68 |
| Number of Analysts | 13 | 12 | 14 | 13 |
| High Estimate | $0.78 | $0.73 | $3.08 | $4.07 |
| Low Estimate | $0.75 | $0.66 | $3.00 | $3.46 |
| Prior Year | $0.67 | $0.58 | $2.69 | $3.05 |
| Growth Rate (Year over Year) | 14.24% | 20.83% | 13.38% | 20.63% |
YoBronomics: $cog $stz $mtn $scty $gwr $open $txrh $ew $fran $odp $bbry $hess http://t.co/IaE50Comyc
11 minutes ago from StockTwits Web
11 minutes ago from StockTwits Web
wisefundmanager: $MRK, $EW, $THOR, $BCRX, $MELA, $RPRX, $ASTM, $AFFX, $BIO, #Bearish, #SELL Signal, #stocks #investing
14 hours ago from InveSocial
14 hours ago from InveSocial
deadmau5mania: @YoBronomics interesting take Michael.. I was thinking of playing the gap fill if it holds 67 with all insider buying.. Will watch it $EW
21 hours ago from Twitter for iPhone
21 hours ago from Twitter for iPhone
abosood1: Commented on StockTwits: $AVEO +0.40 $BAA -0.10 $DV +3.40 $DYAX +0.20 $EW buy 67.50 sold 70.4 $FE +1.10 $KEG -0.10... http://t.co/0FPTiUxieQ
21 hours ago from StockTwits Web
21 hours ago from StockTwits Web
TravKnight1: RT @phisher12: All in all a good week for me was in Cabo can't beat that and was up about 33% this week got super lucky on $ew for 150% gain great week 😃💰
1 day ago from web
1 day ago from web
phisher12: All in all a good week for me was in Cabo can't beat that and was up about 33% this week got super lucky on $ew for 150% gain great week 😃💰
1 day ago from Twitter for iPhone
1 day ago from Twitter for iPhone
ethan780: RT @AndyBiotech: @bradloncar $BAX's past spin-offs:
1992 Caremark($26.5B merger w $CVS in 2007)
1996 Allegiance($5.4B buyout by $CAH in 1998)
2000 $EW $7.6B
2 days ago from Twitter for Android
2 days ago from Twitter for Android
AndyBiotech: @bradloncar $BAX's past spin-offs:
1992 Caremark($26.5B merger w $CVS in 2007)
1996 Allegiance($5.4B buyout by $CAH in 1998)
2000 $EW $7.6B
2 days ago from TweetDeck
2 days ago from TweetDeck
Edwards estimates increased at UBS
EW earnings estimates were increased to reflect additional buybacks, said UBS.
Edwards Lifesciences numbers cut at Credit Suisse
Shares of EW now seen reaching $73, according to Credit Suisse. Estimates also reduced, given higher expected TAVI costs. Neutral rating.
Edwards Lifesciences downgraded at Lazard
EW was downgraded from Buy to Neutral, Lazard Capital Markets said. Company lacks visibility and will post lower earnings growth.
Edwards price target and estimates reduced at UBS
EW earnings estimates through 2015 were reduced significantly after the U.S. TAVI miss and guidance cut, said UBS. Price target goes to $64.
It guides to a very weak third quarter.
Portfolio Mgr. David Peltier analyzes one of the early low-dollar winners of 2013.
Edwards Lifesciences numbers raised at Jefferies
Shares of EW now seen reaching $114, Jefferies said. Estimates also raised on Sapian launch back on track. Buy rating.
Edwards Lifesciences rated new Market Perform at JMP
EW was initiated with a Market Perform rating, JMP Securities said. Company trades at a premium to its peers, but has limited upside earnings potential.
Edwards Lifesciences numbers raised at Citigroup
Shares of EW now seen reaching $98, Citigroup said. Estimates also increased on greater US TAVI revenues. Nuetral rating.
Portfolio Mgr. David Peltier analyzes a low-dollar stock on the verge of a potential turnaround.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
© 2013 TheStreet, Inc. All rights reserved.